Balyasny Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,841
Closed -$48K 2888
2022
Q2
$48K Buy
+26,841
New +$48K ﹤0.01% 1926
2020
Q4
Hold
0
1583
2020
Q3
Sell
-11,569
Closed -$78K 1436
2020
Q2
$78K Buy
+11,569
New +$78K ﹤0.01% 899
2019
Q3
Sell
-392,919
Closed -$5.84M 1540
2019
Q2
$5.84M Sell
392,919
-31,180
-7% -$464K 0.04% 472
2019
Q1
$10.5M Buy
424,099
+41,381
+11% +$1.03M 0.07% 330
2018
Q4
$6.87M Buy
382,718
+78,652
+26% +$1.41M 0.05% 402
2018
Q3
$8.93M Sell
304,066
-76,247
-20% -$2.24M 0.04% 430
2018
Q2
$17.3M Sell
380,313
-88,853
-19% -$4.04M 0.08% 300
2018
Q1
$24.8M Buy
469,166
+155,921
+50% +$8.23M 0.1% 241
2017
Q4
$21.3M Sell
313,245
-186,443
-37% -$12.7M 0.07% 345
2017
Q3
$41.2M Buy
499,688
+53,437
+12% +$4.4M 0.16% 153
2017
Q2
$41.8M Sell
446,251
-648,420
-59% -$60.7M 0.17% 136
2017
Q1
$69.7M Buy
1,094,671
+814,132
+290% +$51.8M 0.33% 57
2016
Q4
$12.5M Sell
280,539
-1,130,287
-80% -$50.2M 0.07% 342
2016
Q3
$50.9M Buy
1,410,826
+1,335,826
+1,781% +$48.2M 0.29% 103
2016
Q2
$1.03M Buy
+75,000
New +$1.03M 0.01% 576
2016
Q1
Sell
-860,204
Closed -$30.1M 1382
2015
Q4
$30.1M Buy
860,204
+376,923
+78% +$13.2M 0.21% 131
2015
Q3
$44.4M Buy
483,281
+417,381
+633% +$38.4M 0.33% 72
2015
Q2
$5.79M Sell
65,900
-151,514
-70% -$13.3M 0.04% 410
2015
Q1
$16.1M Buy
+217,414
New +$16.1M 0.13% 204
2014
Q4
Sell
-166,176
Closed -$7.54M 666
2014
Q3
$7.54M Buy
166,176
+100,533
+153% +$4.56M 0.06% 275
2014
Q2
$2.72M Buy
+65,643
New +$2.72M 0.03% 330